Prokarium

Developer of bacterial immunotherapy treatments for various types of cancer

placeLondon, England, United Kingdom calendar_todayFounded 2012 groups20 employees language prokarium.com

Registered entities

Social engagement

Social engagement: 4.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Riyadh Valley Company, Korea Investment Holdings.

Investor typeCountShare
Venture capital19%
Private equity19%
Accelerator & incubator19%
Bank & private debt218%
Other / undisclosed655%

Recent activity

9 Jun 2026
Event
BIO International
22 May 2026
Event
AUA2026
18 May 2026
Milestone
regulatory
Coming soon